Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Report Publication Announcement 2023

Sep 13, 2023

6785_rns_2023-09-13_0e1bdb26-97ef-49b4-a759-f5c10a2404e7.htm

Report Publication Announcement

Open in viewer

Opens in your device viewer

_________ false

����� ��"� 2 379
EVOGENE LTD
Corporation no: 512838723 13041
- - -
Israel Securities Authority Tel Aviv Stock Exchange C001 ( Public ) Reported via MAGNA: 13/09/2023
www.isa.gov.il www.tase.co.il Reference: 2023-02-106407 Time of broadcast: 11:45 11:45

Report of Periodic or Interim ReportRegulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onUnaudited Condensed Consolidated Interim Financial Statements for the Six Months Ended June 30, 2023

6MFS_and_MDA_-_Accessible_isa.pdf

Link to filing on foreign stock exchange (optional): _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 08/08/2023
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Kofman Guy Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company:
Address: Gad Feinstein St. 13 , Rehovot 7638517 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1